[Our knowledge is patchwork. Survey on the adherence to international guidelines concerning acute and long-term therapy in recurrent depressions and diseases in the schizophrenic field].
In order to assess the observance of international guidelines, 88 psychiatrists and 88 general practitioners (GPs) were asked about their pharmacotherapeutic concepts for depressive and schizophrenic patients with a questionnaire. 47% of the psychiatrists and 72% of the GPs returned their answers. 29% of the psychiatrists and 24% of the GPs treat their depressive patients after an acute episode for six months (in accordance with WHO consensus). 32% of the psychiatrists and 47% of the GPs would suggest prophylactic treatment after two or more depressive episodes as proposed by the WHO. After one or more episodes within the last five years 2.7% of the psychiatrists and 12% of the GPs would start prophylactic treatment as suggested by the WHO. 16% of the psychiatrists and 17% of the GPs would treat a schizophrenic patient after a first episode for 12 to 24 months as proposed by the International Consensus Conference. After two or more psychotic episodes, 16% of the psychiatrists and 31% of the GPs would treat their patients in accordance with international guidelines. The consensus of the WHO for the treatment of depression and the international guidelines for relapse prevention in schizophrenics are hardly known by the examining psychiatrists and GPs and rarely used as treatment guidelines.
Ramseier
F
F
Psychiatrische Dienste des Kantons Aargau, Klinik Königsfelden.
D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy* / Q000517:prevention & control; D005194:Family Practice; D006801:Humans; D017410:Practice Guidelines as Topic; D011570:Psychiatry; D012008:Recurrence; D012559:Schizophrenia / Q000188:drug therapy* / Q000517:prevention & control; D014944:World Health Organization
D000928:Antidepressive Agents; D014150:Antipsychotic Agents
Unser Wissen ist Stückwerk. Eine Umfrage über die Einhaltung internationaler Richtlinien bezüglich akuter und Dauertherapie bei rezidivierenden Depressionen und bei Erkrankungen aus dem schizophrenen Formenkreis.